Gilead Licensing Deal Expands Remdesivir Access, Capacity

Mylan, Cipla, Hetero Labs, Jubilant, Ferozsons Labs Get Rights

 
• By Vibha Ravi
Licensing Pacts Should Address Access and Pricing Concerns • Source: Shutterstock

More from Business

More from Scrip